Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance.
We analyzed the effect of high temperature (a 1-h incubation at 43 degrees C) on the accumulation and cytotoxicity of vinblastine and docetaxel in two model cell lines, K562 and MESSA, and their multidrug resistance (MDR) counterparts, K562/R7 and MESSA/Dx5. High temperature increased the amount of intracellular vinblastine and docetaxel significantly in MESSA cell and, to a much lesser extent, in K562 cells. MDR-positive cells retained a profound drug accumulation defect at 43 degrees C. Hyperthermia enhanced the cytotoxic effect of vinblastine (but not docetaxel) in both K562 and MESSA cells, but not in the MDR-positive variants. PSC833, a potent modulator of P-glycoprotein, induced high levels of drug accumulation in the two MDR-positive cell lines at both 37 degrees C and at 43 degrees C. PSC833 also significantly reduced the resistance levels of the two MDR-positive lines at both 37 degrees C and at 43 degrees C. The effect of hyperthermia on drug accumulation thus seems to depend on the cell line, whereas the effect on cytotoxicity depends on the type of compound. The MDR phenotype remains a therapeutic obstacle at 43 degrees C but is accessible to modulation.
Dumontet
C
C
Laboratoire d'Immunochimie, Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France. cd@hematologie.univ-lyon1.fr
Bodin
F
F
Michal
Y
Y
D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics* / Q000633:toxicity; D001692:Biological Transport; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D000077143:Docetaxel; D018432:Drug Resistance, Multiple / Q000502:physiology*; D006801:Humans; D006979:Hyperthermia, Induced; D004915:Leukemia, Erythroblastic, Acute; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000633:toxicity; D012509:Sarcoma; D043823:Taxoids; D013696:Temperature; D014407:Tumor Cells, Cultured; D014747:Vinblastine / Q000493:pharmacokinetics* / Q000633:toxicity*
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D014747:Vinblastine; D017239:Paclitaxel